Total Valuation
PolyPeptide Group AG has a market cap or net worth of $1.85B. The enterprise value is $913.55.
Market Cap$1.85B
Enterprise Value$913.55
Share Statistics
PolyPeptide Group AG has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PolyPeptide Group AG’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is 1.14%.
Return on Equity (ROE)-0.06
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)1.14%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee272.13K
Profits Per Employee-14.70K
Employee Count1,440
Asset Turnover0.47
Inventory Turnover2.13
Valuation Ratios
The current PE Ratio of PolyPeptide Group AG is ―. PolyPeptide Group AG’s PEG ratio is -5.17.
PE Ratio―
PS Ratio2.36
PB Ratio2.72
Price to Fair Value2.72
Price to FCF-30.38
Price to Operating Cash Flow20.97
PEG Ratio-5.17
Income Statement
In the last 12 months, PolyPeptide Group AG had revenue of 391.87M and earned -21.31M in profits. Earnings per share was -0.64.
Revenue391.87M
Gross Profit64.32M
Operating Income7.41M
Pretax Income-21.41M
Net Income-21.31M
EBITDA44.42M
Earnings Per Share (EPS)-0.64
Cash Flow
In the last 12 months, operating cash flow was 77.08M and capital expenditures -107.38M, giving a free cash flow of -30.30M billion.
Operating Cash Flow77.08M
Free Cash Flow-30.30M
Free Cash Flow per Share-10.00T>
Dividends & Yields
PolyPeptide Group AG pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-222971.36
52-Week Price Change63.82%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
PolyPeptide Group AG upcoming earnings date is Aug 13, 2026, TBA (Confirmed).
Last Earnings DateMar 12, 2026
Next Earnings DateAug 13, 2026
Ex-Dividend Date―
Financial Position
PolyPeptide Group AG as a current ratio of 1.74, with Debt / Equity ratio of 38.33%
Current Ratio1.74
Quick Ratio0.91
Debt to Market Cap0.12
Net Debt to EBITDA1.26
Interest Coverage Ratio0.40
Taxes
In the past 12 months, PolyPeptide Group AG has paid -106.69K in taxes.
Income Tax-106.69K
Effective Tax Rate<0.01
Enterprise Valuation
PolyPeptide Group AG EV to EBITDA ratio is 22.08, with an EV/FCF ratio of -32.22.
EV to Sales2.50
EV to EBITDA22.08
EV to Free Cash Flow-32.22
EV to Operating Cash Flow12.57
Balance Sheet
PolyPeptide Group AG has $74.53M in cash and marketable securities with $130.46M in debt, giving a net cash position of -$55.93M billion.
Cash & Marketable Securities$74.53M
Total Debt$130.46M
Net Cash-$55.93M
Net Cash Per Share-$10.00T>
Tangible Book Value Per Share$9.89
Margins
Gross margin is 16.44%, with operating margin of 1.89%, and net profit margin of -5.44%.
Gross Margin16.44%
Operating Margin1.89%
Pretax Margin-5.46%
Net Profit Margin-5.44%
EBITDA Margin11.34%
EBIT Margin1.89%
Analyst Forecast
The average price target for PolyPeptide Group AG is $50.09, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$50.09
Price Target Upside34.27% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast21.22%
EPS Growth Forecast-7.39%